Stocks · Health care · Biological Products, (No Diagnostic Substances)

REPLIGEN CORP

RGEN Clue Score51
United States Fiscal year ends December CIK 0000730272 Results filed 27 Oct 2026

What the insiders did Mostly scheduled

Nothing of that kind in this period.

What was left out

Form 4 filings counted 42
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 18
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 145,954
History held since 6 Dec 2006